首页> 外文期刊>Molecular biology of the cell >Neurodegeneration-associated mutant TREM2 proteins abortively cycle between the ER and ER-Golgi intermediate compartment
【24h】

Neurodegeneration-associated mutant TREM2 proteins abortively cycle between the ER and ER-Golgi intermediate compartment

机译:Neurocegeneration相关的突变体Trem2蛋白质在ER和ER-GOLGI中间隔室之间造成血液中循环

获取原文
获取原文并翻译 | 示例
           

摘要

Triggering receptor expressed on myeloid cells 2 (TREM2) is a transmembrane protein expressed on microglia within the brain. Several rare mutations in TREM2 cause an early-onset form of neurodegeneration when inherited homozygously. Here we investigate how these mutations affect the intracellular transport of TREM2. We find that most pathogenic TREM2 mutant proteins fail to undergo normal maturation in the Golgi complex and show markedly reduced cell-surface expression. Prior research has suggested that two such mutants are retained in the endoplasmic reticulum (ER), but we find, using a cell-free coat protein complex II (COPII) vesicle budding reaction, that mutant TREM2 is exported efficiently from the ER. In addition, mutant TREM2 becomes sensitive to cleavage by endoglycosidase D under conditions that inhibit recycling to the ER, indicating that it normally reaches a post-ER compartment. Maturation-defective TREM2 mutants are also efficiently bound by a lectin that recognizes O-glycans added in the ER-Golgi intermediate compartment (ERGIC) and cis-Golgi cisterna. Finally, mutant TREM2 accumulates in the ERGIC in cells depleted of COPI. These results indicate that efficient ER export is not sufficient to enable normal cell-surface expression of TREM2. Moreover, our findings suggest that the ERGIC may play an underappreciated role as a quality-control center for mutant and/or malformed membrane proteins.
机译:在骨髓细胞2(Trem2)上表达的触发受体是在脑内的小胶质细胞上表达的跨膜蛋白。 Trem2中的几种罕见突变导致均匀遗传时的早期神经变性形式。在这里,我们调查这些突变如何影响Trem2的细胞内运输。我们发现最致病的Trem2突变蛋白不能在高尔基复合物中进行正常成熟,并显示出显着降低的细胞表面表达。现有研究表明,两种这样的突变体保留在内质网(ER)中保留,但我们发现使用无细胞外壳蛋白质复合物II(COPII)囊泡萌芽反应,从ER有效地出口突变体Trem2。此外,突变体Trem2在抑制对ER再循环的条件下通过内糖苷酶D切割敏感,表明它通常达到ER后隔室。成熟缺陷的Trem2突变体也有效地通过凝集素识别在ER-GOLGI中间隔室(ERGIC)和CIS-GOLGI CISTERN中添加的O-聚糖。最后,突变体Trem2积聚在Copi的细胞中的Ergic中。这些结果表明,有效的ER导出不足以使得Trem2的正常细胞表面表达。此外,我们的研究结果表明,ERGIC可以作为突变体和/或畸形膜蛋白的质量控制中心发挥未被承认的作用。

著录项

  • 来源
    《Molecular biology of the cell》 |2017年第20期|共11页
  • 作者单位

    Univ Calif Berkeley Dept Mol &

    Cell Biol Howard Hughes Med Inst Berkeley CA 94720 USA;

    Univ Calif Berkeley Dept Mol &

    Cell Biol Howard Hughes Med Inst Berkeley CA 94720 USA;

    Univ Calif Berkeley Dept Mol &

    Cell Biol Howard Hughes Med Inst Berkeley CA 94720 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分子生物学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号